Center for International Blood & Marrow Transplant Research (CIBMTR)

03/25/2026

Today at : Hear about outcomes from the NMDP-sponsored ACCESS trial:

03/24/2026

Live at today: CIBMTR oral and poster abstracts! Take a look:

03/23/2026

📢 Now Hiring: Program Director I, Statistical Operations – CIBMTR (Hybrid | Wisconsin)

The Center for International Blood and Marrow Transplant Research (CIBMTR) at the Medical College of Wisconsin is seeking a Program Director I to direct the CIBMTR statistical operations functional area.

In this role, you’ll provide strategic direction and hands‑on leadership to biostatistics teams, partnering closely with medical and scientific researchers across the entire research lifecycle—from study and project design to data collection, management, and analysis, through interpretation of results, reporting, and publication.

This is an exciting opportunity to collaborate with world‑class investigators, mentor expert statistical teams, and help drive high‑impact research that advances blood and marrow transplant outcomes globally.
🔹 Hybrid (Wisconsin)
🔹 Leadership and collaboration focus
🔹 Impactful, mission‑driven research environment
🔹 Education: Bachelor’s degree required; Master’s in Statistics, Biostatistics, or MPH preferred

👉 Learn more and apply:
https://mcw.wd503.myworkdayjobs.com/ExternalCareers/job/Remote-Wisconsin/Program-Director-I---CIBMTR_JR101330

03/23/2026

Attending ? Make sure to check out these abstracts today. Don’t miss these oral and poster abstracts!

03/22/2026

begins today! Here’s the full schedule of CIBMTR abstracts being presented this week.

03/20/2026

Coming soon to : CIBMTR will present a variety of oral and poster abstracts. Here’s a quick overview of when this research will be featured throughout the meeting.

03/18/2026

New tool predicts acute graft-vs-host disease after transplant. Read about this CIBMTR study to learn more:https://cibmtr.org/Patient-Summaries/New-tool-predicts-acute-graft-vs-host-disease-after-transplant.htm

03/07/2026

We're gearing up for in Orlando, Florida! Tune in for registration dates, abstract submissions, and more as they become available in Tandem Meeting News:

Start preparing for our next gathering in Florida by reading about abstract submission deadlines and ongoing plans for four days of scientific programming.

03/06/2026

Combinational therapies, engineered cells, off-the-shelf allogeneic projects, and in vivo cell programming may define the next era of progress, according to Stephen Gottschalk, MD. Read more about this session in Tandem Meeting News:

Stephen Gottschalk, MD, says combinational therapies, engineered cells, off-the-shelf allogeneic cells and in vivo cell programming are likely to provide the next advances.

03/05/2026

Beyond the bench and bedside, social workers at shared key insights for addressing barriers tied to social determinants of health. Find out more about this session in Tandem Meeting News: https://www.tandemmeetingsnews.com/social-workers-discuss-how-collaboration-with-nurses-can-improve-patient-care-in-cell-therapy/?utm_source=facebook&utm_medium=social&utm_campaign=CIBMTR-2026-Post2-assoc-facebook-share-custom-graphic&utm_content=link-share

03/04/2026

What challenges arise when applying artificial intelligence to cellular therapy? Experts explore the answers and more in this APP Track Session. Read more in Tandem Meeting News: https://www.tandemmeetingsnews.com/panel-examines-prospects-for-applying-ai-to-patient-support-risk-prediction-and-more-in-bmt/?utm_source=facebook&utm_medium=social&utm_campaign=CIBMTR-2026-Post2-assoc-facebook-share-custom-graphic&utm_content=link-share

03/03/2026

At , Michael J. Eckrich, MD, MPH, challenged attendees to prioritize patients and training to bring advances in gene editing into the clinic. Get the details in Tandem Meeting News:

Michael J. Eckrich, MD, MPH, urges the audience to prioritize patients and training in order to bring gene editing advances into the clinic.